Goiter pathophysiology: Difference between revisions

	Goiter Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Goiter from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Goiter pathophysiology On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Goiter pathophysiology All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Goiter pathophysiology
CDC on Goiter pathophysiology
Goiter pathophysiology in the news
Blogs on Goiter pathophysiology
Directions to Hospitals Treating Cushing’s disease
Risk calculators and risk factors for Goiter pathophysiology

VisualWikitext

Revision as of 02:36, 8 September 2017

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

The exact pathogenesis of [disease name] is not fully understood.

OR

It is thought that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].

OR

[Pathogen name] is usually transmitted via the [transmission route] route to the human host.

OR

Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.

OR

[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].

OR

The progression to [disease name] usually involves the [molecular pathway].

OR

The pathophysiology of [disease/malignancy] depends on the histological subtype.

Pathophysiology

Pathogenesis

The exact pathogenesis of [disease name] is not fully understood.

OR

It is thought that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
[Pathogen name] is usually transmitted via the [transmission route] route to the human host.
Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
The progression to [disease name] usually involves the [molecular pathway].
The pathophysiology of [disease/malignancy] depends on the histological subtype.

Genetics

[Disease name] is transmitted in [mode of genetic transmission] pattern.
Genes involved in the pathogenesis of [disease name] include [gene1], [gene2], and [gene3].
The development of [disease name] is the result of multiple genetic mutations.

Associated Conditions

Gross Pathology

On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].

Microscopic Pathology

On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].

References

Template:WH Template:WS

@@ Line 4: / Line 4: @@
 {{CMG}}; {{AE}}
 ==Overview==
-There is no established system for the classification of [disease name].
+The exact pathogenesis of [disease name] is not fully understood.
 OR
-[Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4].
+It is thought that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
 OR
-[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3].
+[Pathogen name] is usually transmitted via the [transmission route] route to the human host.
-[Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].
 OR
-Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
+Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
 OR
-If the staging system involves specific and characteristic findings and features:
-According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
+[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
 OR
-The staging of [malignancy name] is based on the [staging system].
+The progression to [disease name] usually involves the [molecular pathway].
 OR
-There is no established system for the staging of [malignancy name].
+The pathophysiology of [disease/malignancy] depends on the histological subtype.
-==Classification==
+==Pathophysiology==
-*There is no established system for the classification of [disease name].
+===Pathogenesis===
+*The exact pathogenesis of [disease name] is not fully understood.
 OR
-*[Disease name] may be classified according to [classification method] into [number] subtypes/groups:
+*It is thought that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
-**[Group1]
+*[Pathogen name] is usually transmitted via the [transmission route] route to the human host.
-**[Group2]
+*Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
-**[Group3]
+*[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
-**[Group4]
+*The progression to [disease name] usually involves the [molecular pathway].
-OR
+*The pathophysiology of [disease/malignancy] depends on the histological subtype.
-*[Disease name] may be classified into [large number > 6] subtypes based on:
-**[Classification method 1]
+==Genetics==
-**[Classification method 2]
+*[Disease name] is transmitted in [mode of genetic transmission] pattern.
-**[Classification method 3]
+*Genes involved in the pathogenesis of [disease name] include [gene1], [gene2], and [gene3].
-*[Disease name] may be classified into several subtypes based on:
+*The development of [disease name] is the result of multiple genetic mutations.
-**[Classification method 1]
+==Associated Conditions==
-**[Classification method 2]
-**[Classification method 3]
+==Gross Pathology==
-OR
+*On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
-*Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
-OR
+==Microscopic Pathology==
-*If the staging system involves specific and characteristic findings and features:
+*On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
-*According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
-OR
-*The staging of [malignancy name] is based on the [staging system].
-OR
-*There is no established system for the staging of [malignancy name].
 ==References==
 {{Reflist|2}}
 {{WH}}
 {{WS}}